{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:06:59Z","timestamp":1770491219475,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41443-020-0247-3","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T10:02:54Z","timestamp":1583748174000},"page":"251-258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A modern review of penile traction monotherapy and combination therapy for the treatment of peyronie\u2019s disease"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5943-0185","authenticated-orcid":false,"given":"Raevti","family":"Bole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niki","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevann","family":"Helo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Ziegelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"key":"247_CR1","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1038\/sj.ijir.3901081","volume":"15","author":"WJ Hellstrom","year":"2003","unstructured":"Hellstrom WJ. History, epidemiology, and clinical presentation of Peyronie\u2019s disease. Int J Impot Res. 2003;15:S91\u201392.","journal-title":"Int J Impot Res"},{"key":"247_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.ijir.3901518","volume":"19","author":"M Arafa","year":"2007","unstructured":"Arafa M, Eid H, El-Badry A, Ezz-Eldine K, Shamloul R. The prevalence of Peyronie\u2019s disease in diabetic patients with erectile dysfunction. Int J Impot Res. 2007;19:213\u20137.","journal-title":"Int J Impot Res"},{"key":"247_CR3","doi-asserted-by":"publisher","first-page":"282503","DOI":"10.1155\/2011\/282503","volume":"2011","author":"DB Dibenedetti","year":"2011","unstructured":"Dibenedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X. A population-based study of Peyronie\u2019s disease: prevalence and treatment patterns in the United States. Adv Urol. 2011;2011:282503.","journal-title":"Adv Urol"},{"key":"247_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1159\/000049830","volume":"40","author":"G La Pera","year":"2001","unstructured":"La Pera G, Pescatori ES, Calabrese M, Boffini A, Colombo F, Andriani E, et al. Peyronie\u2019s disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years. Eur Urol. 2001;40:525\u201330.","journal-title":"Eur Urol"},{"key":"247_CR5","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","volume":"171","author":"JP Mulhall","year":"2004","unstructured":"Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, et al. Subjective and objective analysis of the prevalence of Peyronie\u2019s disease in a population of men presenting for prostate cancer screening. J Urol. 2004;171:2350\u20133.","journal-title":"J Urol"},{"key":"247_CR6","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/jsm.12082","volume":"10","author":"E Chung","year":"2013","unstructured":"Chung E, De Young L, Solomon M, Brock GB. Peyronie\u2019s disease and mechanotransduction: an in vitro analysis of the cellular changes to Peyronie\u2019s disease in a cell-culture strain system. J Sex Med. 2013;10:1259\u201367.","journal-title":"J Sex Med"},{"key":"247_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.21037\/tau.2016.05.14","volume":"5","author":"JE Terrier","year":"2016","unstructured":"Terrier JE, Nelson CJ. Psychological aspects of Peyronie\u2019s disease. Transl Androl Urol. 2016;5:290\u20135.","journal-title":"Transl Androl Urol"},{"key":"247_CR8","unstructured":"Scroppo FI, Mancini M, Maggi M, Colpi GM. Can an external penis stretcher reduce Peyronie's penile curvature? Int J Impot Res. 2001;13."},{"key":"247_CR9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1743-6109.2008.01108.x","volume":"6","author":"P Gontero","year":"2009","unstructured":"Gontero P, Di Marco M, Giubilei G, Bartoletti R, Pappagallo G, Tizzani A, et al. Use of penile extender device in the treatment of penile curvature as a result of Peyronie\u2019s disease. Results of a phase II prospective study. J Sex Med. 2009;6:558\u201366.","journal-title":"J Sex Med"},{"key":"247_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jsm.12400","volume":"11","author":"JI Martinez-Salamanca","year":"2014","unstructured":"Martinez-Salamanca JI, Egui A, Moncada I, Minaya J, Ballesteros CM, Del Portillo L, et al. Acute phase Peyronie\u2019s disease management with traction device: a nonrandomized prospective controlled trial with ultrasound correlation. J Sex Med. 2014;11:506\u201315.","journal-title":"J Sex Med"},{"key":"247_CR11","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/j.1743-6109.2008.00814.x","volume":"5","author":"LA Levine","year":"2008","unstructured":"Levine LA, Newell M, Taylor FL. Penile traction therapy for treatment of Peyronie\u2019s disease: a single-center pilot study. J Sex Med. 2008;5:1468\u201373.","journal-title":"J Sex Med"},{"key":"247_CR12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/bju.14602","volume":"123","author":"I Moncada","year":"2019","unstructured":"Moncada I, Krishnappa P, Romero J, Torremade J, Fraile A, Martinez-Salamanca JI, et al. Penile traction therapy with the new device \u2018Penimaster PRO\u2019 is effective and safe in the stable phase of Peyronie\u2019s disease: a controlled multicentre study. BJU Int. 2019;123:694\u2013702.","journal-title":"BJU Int"},{"key":"247_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.juro.2013.01.090","volume":"190","author":"WJ Hellstrom","year":"2013","unstructured":"Hellstrom WJ, Feldman R, Rosen RC, Smith T, Kaufman G, Tursi J. Bother and distress associated with Peyronie\u2019s disease: validation of the Peyronie\u2019s disease questionnaire. J Urol. 2013;190:627\u201334.","journal-title":"J Urol"},{"key":"247_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.urology.2017.01.054","volume":"104","author":"MJ Ziegelmann","year":"2017","unstructured":"Ziegelmann MJ, Viers BR, Montgomery BD, Avant RA, Savage JB, Trost LW. Clinical experience with penile traction therapy among men undergoing collagenase clostridium histolyticum for Peyronie disease. Urology. 2017;104:102\u20139.","journal-title":"Urology"},{"key":"247_CR15","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.juro.2015.06.096","volume":"194","author":"CA Stewart","year":"2015","unstructured":"Stewart CA, Yafi FA, Knoedler M, Mandava SH, McCaslin IR, Sangkum P, et al. Intralesional injection of Interferon-alpha2b improves penile curvature in men with Peyronie\u2019s disease independent of plaque location. J Urol. 2015;194:1704\u20137.","journal-title":"J Urol"},{"key":"247_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/JU.0000000000000245","volume":"202","author":"M Ziegelmann","year":"2019","unstructured":"Ziegelmann M, Savage J, Toussi A, Alom M, Yang D, Kohler T, et al. Outcomes of a novel penile traction device in men with peyronie\u2019s disease: a randomized, single-blind, controlled trial. J Urol. 2019;202:599\u2013610.","journal-title":"J Urol"},{"key":"247_CR17","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.eururo.2011.07.053","volume":"60","author":"RC Rosen","year":"2011","unstructured":"Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol. 2011;60:1010\u20136.","journal-title":"Eur Urol"},{"key":"247_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.esxm.2019.07.003","volume":"7","author":"A Ibrahim","year":"2019","unstructured":"Ibrahim A, Gazzard L, Alharbi M, Rompre-Brodeur A, Aube M, Carrier S. Evaluation of oral pentoxifylline, colchicine, and penile traction for the management of Peyronie\u2019s disease. Sex Med. 2019;7:459\u201363.","journal-title":"Sex Med"},{"key":"247_CR19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1743-6109.2011.02519.x","volume":"9","author":"MR Abern","year":"2012","unstructured":"Abern MR, Larsen S, Levine LA. Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie\u2019s disease. J Sex Med. 2012;9:288\u201395.","journal-title":"J Sex Med"},{"key":"247_CR20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.juro.2015.03.092","volume":"194","author":"FA Yafi","year":"2015","unstructured":"Yafi FA, Pinsky MR, Stewart C, Sangkum P, Ates E, Trost LW, et al. The effect of duration of penile traction therapy in patients undergoing intralesional injection therapy for Peyronie\u2019s disease. J Urol. 2015;194:754\u20138.","journal-title":"J Urol"},{"key":"247_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.acuro.2018.08.005","volume":"43","author":"L Gallo","year":"2019","unstructured":"Gallo L, Sarnacchiaro P. Ten-year experience with multimodal treatment for acute phase Peyronie\u2019s disease: a real life clinical report. Actas Urol Esp. 2019;43:182\u20139.","journal-title":"Actas Urol Esp"},{"key":"247_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","volume":"190","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190:199\u2013207.","journal-title":"J Urol"},{"key":"247_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/jsm.12731","volume":"12","author":"LA Levine","year":"2015","unstructured":"Levine LA, Cuzin B, Mark S, Gelbard MK, Jones NA, Liu G, et al. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie\u2019s disease: a phase 3 open-label study. J Sex Med. 2015;12:248\u201358.","journal-title":"J Sex Med"},{"key":"247_CR24","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1016\/j.juro.2012.01.032","volume":"187","author":"M Gelbard","year":"2012","unstructured":"Gelbard M, Lipshultz LI, Tursi J, Smith T, Kaufman G, Levine LA. Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease. J Urol. 2012;187:2268\u201374.","journal-title":"J Urol"},{"key":"247_CR25","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jsxm.2019.03.007","volume":"16","author":"M Alom","year":"2019","unstructured":"Alom M, Sharma KL, Toussi A, Kohler T, Trost L. Efficacy of combined collagenase clostridium histolyticum and restoreX penile traction therapy in men with Peyronie\u2019s disease. J Sex Med. 2019;16:891\u2013900.","journal-title":"J Sex Med"},{"key":"247_CR26","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1111\/j.1743-6109.2012.02849.x","volume":"9","author":"J Rybak","year":"2012","unstructured":"Rybak J, Papagiannopoulos D, Levine L. A retrospective comparative study of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie\u2019s disease: measured lengths and patient perceptions. J Sex Med. 2012;9:2396\u2013403.","journal-title":"J Sex Med"},{"key":"247_CR27","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1111\/j.1743-6109.2011.02285.x","volume":"8","author":"LA Levine","year":"2011","unstructured":"Levine LA, Rybak J. Traction therapy for men with shortened penis prior to penile prosthesis implantation: a pilot study. J Sex Med. 2011;8:2112\u20137.","journal-title":"J Sex Med"},{"key":"247_CR28","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jsxm.2019.06.010","volume":"16","author":"K Wymer","year":"2019","unstructured":"Wymer K, Kohler T, Trost L. Comparative cost-effectiveness of surgery, collagenase clostridium histolyticum, and penile traction therapy in men with peyronie\u2019s disease in an era of effective clinical treatment. J Sex Med. 2019;16:1421\u201332.","journal-title":"J Sex Med"},{"key":"247_CR29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.21037\/tau.2016.05.01","volume":"5","author":"R Chen","year":"2016","unstructured":"Chen R, McCraw C, Lewis R. Plication procedures-excisional and incisional corporoplasty and imbrication for Peyronie\u2019s disease. Transl Androl Urol. 2016;5:318\u201333.","journal-title":"Transl Androl Urol"},{"key":"247_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.urology.2018.07.039","volume":"122","author":"NM Haney","year":"2018","unstructured":"Haney NM, Kohn TP, Nichols PE, Jg Hellstrom W. The effect of adjunct mechanical traction on penile length in men undergoing primary treatment for peyronie\u2019s disease: a systematic review and meta-analysis. Urology. 2018;122:110\u20135.","journal-title":"Urology"},{"key":"247_CR31","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1111\/j.1743-6109.2009.01662.x","volume":"8","author":"M Nikoobakht","year":"2011","unstructured":"Nikoobakht M, Shahnazari A, Rezaeidanesh M, Mehrsai A, Pourmand G. Effect of penile-extender device in increasing penile size in men with shortened penis: preliminary results. J Sex Med. 2011;8:3188\u201392.","journal-title":"J Sex Med"},{"key":"247_CR32","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/jsm.12870","volume":"12","author":"MR Nowroozi","year":"2015","unstructured":"Nowroozi MR, Amini E, Ayati M, Jamshidian H, Radkhah K, Amini S. Applying extender devices in patients with penile dysmorphophobia: assessment of tolerability, efficacy, and impact on erectile function. J Sex Med. 2015;12:1242\u20137.","journal-title":"J Sex Med"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41443-020-0247-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-020-0247-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-020-0247-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:31:20Z","timestamp":1684618280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-020-0247-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["247"],"URL":"https:\/\/doi.org\/10.1038\/s41443-020-0247-3","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"3 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}